Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
CERo Therapeutics, Inc. logo — Tumor Cell Clearance Reimagined.

CERo Therapeutics, Inc.

Tumor Cell Clearance Reimagined.

Founded 2017 United States South San Francisco, United States 16 employees Series A Total: $41.40M Biotechnology, Health and Wellness

General Information

Company Name CERo Therapeutics, Inc.
Founded Year 2017
Location United States South San Francisco, United States +1
Founders / Decision Makers
Team member
Employees 16
Industries Biotechnology, Health and Wellness
Funding Stage Series A
Social

Get notified when CERo Therapeutics, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About CERo Therapeutics, Inc.

CERo Therapeutics, Inc., founded in 2017, is a promising player in the Biotechnology and Health and Wellness sectors. Headquartered in the United States, this innovative company is reimagining tumor cell clearance under its slogan, "Tumor Cell Clearance Reimagined."

The company is leveraging its expertise in cellular clearance and molecular immunology to develop a novel class of engineered cell therapies. By engaging new and complementary cell elimination pathways, CERo aims to deliver deeper and more sustained clinical responses, ultimately enhancing patient wellness.

The company attracted significant attention with a $40.00M Series A investment in March 2020. This funding round was led by notable investors including Arch Venture Partners, Lyell Immunopharma, Altitude Life Science Ventures, and Sequoia Capital China, signaling strong confidence in CERo Therapeutics' strategic direction and innovative approach.

Taxonomy: Cellular Immunotherapy, Adoptive Cell Therapy, Immuno Oncology, Synthetic Biology, Gene Engineering, Flow Cytometry, Immunology, Tumor Immunology, Solid Tumors, Molecular Immunology, Molecular Biology, Hematopoietic Cell Transplantation

Services & Products

Development of curative cell therapies
Customization of T-cell platforms
Integration of immune system capabilities

Target Customers

Healthcare Providers Research Institutions Oncologists Biotechnology Investors Pharmaceutical Companies

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Series A •••••• 4
Investor Investor
•••• •••• 		18 Mar 2020
Seed Round •••••• - 12 Mar 2017

CERo Therapeutics, Inc. Alternatives & Competitors

View All Alternatives
CERo Therapeutics, Inc. vs
Cogen Therapeutics
Cogen Therapeutics

Pioneering immune modulation to specifically address disease drivers, redefining immunological healt...

Biotechnology
CERo Therapeutics, Inc. vs
Kisker Biotech GmbH & Co. KG
Kisker Biotech GmbH & Co. KG

Supplying you the best consumables and equipment !

8 employees
Biotechnology, E-Commerce
CERo Therapeutics, Inc. vs
Nordic Biosite
Nordic Biosite Sweden

By Your Side in Life Science Research

25 employees
Biotechnology, Life Sciences
View all alternatives

FAQ About CERo Therapeutics, Inc.

Tumor Cell Clearance Reimagined.
CERo Therapeutics, Inc. was founded in 2017.
CERo Therapeutics, Inc. is headquartered in South San Francisco, United States.
CERo Therapeutics, Inc. operates in the following industries: Biotechnology, Health and Wellness.
CERo Therapeutics, Inc. has approximately 16 employees.
CERo Therapeutics, Inc. has completed 2 funding rounds, raising a total of $41.40M. The latest funding stage is Series A.
CERo Therapeutics, Inc. offers: Development of curative cell therapies, Customization of T-cell platforms, Integration of immune system capabilities.
Top alternatives and competitors to CERo Therapeutics, Inc. include Cogen Therapeutics, Kisker Biotech GmbH & Co. KG, Nordic Biosite, BioTether Sciences Inc., GeneBio Systems, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
CERo Therapeutics, Inc. and Cogen Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors CERo Therapeutics, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy